Diverse perspectives on science and medicine
Paul Simpson, Deputy Editor of PLOS Medicine, looks forward to this year’s Médecins Sans Frontières Scientific Days. One of the highlights of my year is to attend the Médecins Sans Frontières (MSF) Scientific Days, a conference
As the Third International Conference on Financing for Development begins in Ethiopia, Áine Markham of Médecins Sans Frontières warns that basing funding decisions on country-level finance indicators could be a step backwards for global health, especially in middle-income countries.
A version of this was published in Le Temps on 31 October 2014 Thomas Nierle and Bruno Jochum of Médecins Sans Frontières emphasize the responsibility of governments to lead the response to disasters like the
Grania Brigden (@TBBrigden) discusses the urgent need to close the gaps in the TB response. The 45th Union World Conference on Lung Health held in Barcelona last week opened with the Health Ministers of South
On November 5, 2014, the WHO, WIPO and WTO will hold a joint symposium to discuss innovation and access to medical technologies in middle-income countries. In this post, Judit Rius Sanjuan and Rohit Malpani of Médecins
Grazia Caleo of Médecins Sans Frontières (MSF) UK describes her experiences as a medical epidemiologist during the Ebola outbreak in Kailhun, Sierra Leone. In José Saramago’s book, Blindness, he describes an epidemic of an unknown
PLOS Medicine and BioMed Central are proud to be co-sponsoring this year’s MSF Scientific Day and have co-written this joint blog on both the Speaking of Medicine and the BioMed Central blog to mark the
On World TB day patient advocate Goodman Makhanda and Dr Jennifer Hughes from Médecins Sans Frontières reflect on successes and challenges of tackling TB in Khayelitsha, South Africa. Two weeks ago there was a small
Tane Luna Ramirez from Médecins Sans Frontières reflects on the challenges of providing care for pregnant women as well as the heightened risk of sexual violence in disaster settings. Today, as International Women’s Day approaches,
Manica Balasegaram from the Médecins Sans Frontières (MSF) Access Campaign, reflects on a research and development system that is failing the world’s poorest people. The past month has seen the reputation of Big Pharma dented